Platt FM - Search Results

1

Immune dysfunction in Niemann-Pick disease type C.

Platt N, Speak AO, Colaco A, Gray J, Smith DA, Williams IM, Wallom KL, Platt FM. Platt N, et al. Among authors: platt fm. J Neurochem. 2016 Jan;136 Suppl 1(Suppl Suppl 1):74-80. doi: 10.1111/jnc.13138. Epub 2015 Jun 4. J Neurochem. 2016. PMID: 25946402 Free PMC article. Review.

2

Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis.

Jeyakumar M, Thomas R, Elliot-Smith E, Smith DA, van der Spoel AC, d'Azzo A, Perry VH, Butters TD, Dwek RA, Platt FM. Jeyakumar M, et al. Among authors: platt fm. Brain. 2003 Apr;126(Pt 4):974-87. doi: 10.1093/brain/awg089. Brain. 2003. PMID: 12615653

3

Accumulation of glycosphingolipids in Niemann-Pick C disease disrupts endosomal transport.

te Vruchte D, Lloyd-Evans E, Veldman RJ, Neville DC, Dwek RA, Platt FM, van Blitterswijk WJ, Sillence DJ. te Vruchte D, et al. Among authors: platt fm. J Biol Chem. 2004 Jun 18;279(25):26167-75. doi: 10.1074/jbc.M311591200. Epub 2004 Apr 12. J Biol Chem. 2004. PMID: 15078881 Free article.

4

Improved outcome of N-butyldeoxygalactonojirimycin-mediated substrate reduction therapy in a mouse model of Sandhoff disease.

Andersson U, Smith D, Jeyakumar M, Butters TD, Borja MC, Dwek RA, Platt FM. Andersson U, et al. Among authors: platt fm. Neurobiol Dis. 2004 Aug;16(3):506-15. doi: 10.1016/j.nbd.2004.04.012. Neurobiol Dis. 2004. PMID: 15262262

5

Treatment with miglustat reverses the lipid-trafficking defect in Niemann-Pick disease type C.

Lachmann RH, te Vruchte D, Lloyd-Evans E, Reinkensmeier G, Sillence DJ, Fernandez-Guillen L, Dwek RA, Butters TD, Cox TM, Platt FM. Lachmann RH, et al. Among authors: platt fm. Neurobiol Dis. 2004 Aug;16(3):654-8. doi: 10.1016/j.nbd.2004.05.002. Neurobiol Dis. 2004. PMID: 15262277

6

NSAIDs increase survival in the Sandhoff disease mouse: synergy with N-butyldeoxynojirimycin.

Jeyakumar M, Smith DA, Williams IM, Borja MC, Neville DC, Butters TD, Dwek RA, Platt FM. Jeyakumar M, et al. Among authors: platt fm. Ann Neurol. 2004 Nov;56(5):642-9. doi: 10.1002/ana.20242. Ann Neurol. 2004. PMID: 15505823

7

Implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammals.

Speak AO, Salio M, Neville DC, Fontaine J, Priestman DA, Platt N, Heare T, Butters TD, Dwek RA, Trottein F, Exley MA, Cerundolo V, Platt FM. Speak AO, et al. Among authors: platt fm, platt n. Proc Natl Acad Sci U S A. 2007 Apr 3;104(14):5971-6. doi: 10.1073/pnas.0607285104. Epub 2007 Mar 19. Proc Natl Acad Sci U S A. 2007. PMID: 17372214 Free PMC article.

8

Beneficial effects of substrate reduction therapy in a mouse model of GM1 gangliosidosis.

Elliot-Smith E, Speak AO, Lloyd-Evans E, Smith DA, van der Spoel AC, Jeyakumar M, Butters TD, Dwek RA, d'Azzo A, Platt FM. Elliot-Smith E, et al. Among authors: platt fm. Mol Genet Metab. 2008 Jun;94(2):204-11. doi: 10.1016/j.ymgme.2008.02.005. Epub 2008 Apr 1. Mol Genet Metab. 2008. PMID: 18387328

9

[Glycosphingolipids Gb3 and iGb3. In vivo roles in hemolytic-uremic syndrome and iNKT cell function].

Porubsky S, Luckow B, Bonrouhi M, Speak A, Cerundolo V, Platt F, Gröne HJ. Porubsky S, et al. Pathologe. 2008 Nov;29 Suppl 2:297-302. doi: 10.1007/s00292-008-1040-0. Pathologe. 2008. PMID: 18810447 German.

10

Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium.

Lloyd-Evans E, Morgan AJ, He X, Smith DA, Elliot-Smith E, Sillence DJ, Churchill GC, Schuchman EH, Galione A, Platt FM. Lloyd-Evans E, et al. Among authors: platt fm. Nat Med. 2008 Nov;14(11):1247-55. doi: 10.1038/nm.1876. Epub 2008 Oct 26. Nat Med. 2008. PMID: 18953351

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

258 results

Search Page